# Canadian Amyloidosis Society (CAS) Website - Content Documentation

This document provides a comprehensive overview of all content used across the Canadian Amyloidosis Society website, organized by pages and sections. The website supports both English and French languages with consistent brand messaging.

> **Note:** For design guidelines (colors, typography, components, theme system), see [`design-guidelines.md`](./design-guidelines.md).

---

## 1. HOMEPAGE (/)

### Hero Section
**English:**
- **Main Title**: "Canadian Amyloidosis Society (CAS)"
- **Subtitle**: "Accelerating awareness, advancing care, and supporting patients across Canada through evidence-based resources and professional collaboration."
- **CTA Buttons**: 
  - "Get Involved" (links to /get-involved)
  - "Browse Directory" (links to /directory)
  - "Upload Resource" (links to /upload-resource)
  - "Learn More" (links to /about-amyloidosis)

**French:**
- **Main Title**: "Société Canadienne d'Amyloïdose (SCA)"
- **Subtitle**: "Accélérer la sensibilisation, faire progresser les soins et soutenir les patients à travers le Canada grâce à des ressources fondées sur des preuves et une collaboration professionnelle."

### Welcome Section
**Core Message**: Platform introduction focusing on clinical excellence and patient support

### About Amyloidosis Section
**Content Areas:**
- **Types of Amyloidosis**: AL, ATTR, and Other rare types
- **Early Detection**: Importance and warning signs
- **Treatment Options**: Modern therapeutic approaches
- **Statistical Data**: Patient outcomes and diagnostic timelines

### What You'll Find Here Section
**Three Main Categories:**
1. **Filterable Clinic Directory**
   - Geographic healthcare center listings
   - Specialty services mapping
   - Contact information and services

2. **Peer-Submitted Tools**
   - Clinical assessment tools
   - Diagnostic aids
   - Treatment protocols
   - Peer-reviewed content

3. **Evidence Summaries**
   - Treatment efficacy data
   - Clinical practice guidelines
   - Research findings

### Directory Preview Section
**Interactive Map Features:**
- **Cluster Legend**: 10+ centers (blue), 5-9 (green), 2-4 (light blue), 1 center (orange)
- **Network Stats**: Total centers, active provinces, coverage statistics
- **Province Details**: Individual healthcare center information

### Events & Newsletter Section
**Content Types:**
- **Upcoming Events**: CAS Journal Club, CANN Educational Series
- **Recent Activities**: Conference updates, webinar summaries
- **Newsletter Signup**: Professional updates and announcements
- **Statistics Cards**: Member engagement metrics

### Quick Links Section
**Six Action Categories:**
1. **Join CAS**: Membership information
2. **Upload Resource**: Content submission
3. **Browse Directory**: Healthcare provider search
4. **Contact Us**: Support and inquiries
5. **Get Involved**: Volunteer opportunities
6. **Access Resources**: Clinical tools and materials

### Featured Spotlights Section
**Content Categories:**
- **Success Stories**: Patient and provider testimonials
- **Research Updates**: Latest clinical findings
- **News & Announcements**: Organization updates
- **Educational Content**: Medical professional resources

---

## 2. ABOUT CAS PAGE (/about)

### Hero Section
**English:**
- **Title**: "About the Canadian Amyloidosis Society"
- **Subtitle**: "Building Canada's leading platform for amyloidosis care through clinical excellence, evidence-based resources, and collaborative professional networks."
- **Badge**: "National Platform"

### Core Mission
**Three Pillars:**
1. **Tool Curation**: Evidence-based clinical tools and protocols
2. **Diagnostic Support**: Rapid diagnostic pathways and decision tools
3. **Peer Learning**: Collaborative networks and professional development

### Executive Committee
**Six Committee Members:**
- Dr. Sarah Chen - Medical Director
- Dr. Michael Thompson - Clinical Research Lead
- Dr. Jennifer Walsh - Patient Care Coordinator
- Dr. David Kumar - Technology Integration
- Dr. Lisa Martinez - Community Outreach
- Dr. Robert Fraser - Quality Assurance

### Governance Documents
**Three Categories:**
1. **Policy Documents**: 
   - Annual Financial Report
   - Audit Results
   - Funding Sources
   - Impact Metrics

2. **Clinical Guidelines**:
   - Evidence-based protocols
   - Diagnostic criteria
   - Treatment pathways
   - Quality standards

3. **Transparency Reports**:
   - Organizational structure
   - Decision-making processes
   - Accountability measures
   - Public disclosures

### Impact Statistics
- **6-week diagnosis**: Reduced diagnostic timeline
- **25+ centers**: Network coverage
- **1,200+ patients**: Served annually

---

## 3. ABOUT AMYLOIDOSIS PAGE (/about-amyloidosis)

### Hero Section
**Professional Focus:**
- **Title**: "About Amyloidosis"
- **Subtitle**: "Learn the signs, understand the types, and take action early."
- **Target Audience**: PCPs, cardiologists, neurologists, nephrologists, hematologists

### Overview Section
**Simplified Pathophysiology:**
- Protein misfolding explanation
- Organ involvement patterns
- Disease progression timeline

### Types of Amyloidosis
**Three Main Categories:**

1. **AL Amyloidosis (Light Chain)**
   - Hematologic origin
   - Multi-organ involvement
   - Treatment approaches

2. **ATTR Amyloidosis (Transthyretin)**
   - Hereditary and wild-type variants
   - Cardiac and neurologic manifestations
   - Therapeutic options

3. **Other/Rare Types**
   - AA Amyloidosis
   - Localized forms
   - Dialysis-related amyloidosis

### Clinical Red Flags
**High-Risk Presentations vs Supporting Features:**
- Unexplained heart failure
- Peripheral neuropathy
- Proteinuria and kidney dysfunction
- Gastrointestinal symptoms

### Diagnostic Pathway
**5-Step Evidence-Based Approach:**
1. Clinical suspicion
2. Initial screening
3. Confirmatory testing
4. Typing studies
5. Subtype classification

### Clinical Guidelines
**External Resources:**
- Canadian Cardiovascular Society (CCS) Guidelines
- Mayo Clinic Protocols
- NHS Treatment Standards

---

## 4. DIRECTORY PAGE (/directory)

### Hero Section
**Professional Network Focus:**
- **Title**: "Healthcare Provider Directory"
- **Subtitle**: "Connect with amyloidosis specialists and treatment centers across Canada"
- **Search Features**: Geographic and specialty filtering

### Interactive Map
**Province-by-Province Coverage:**
- All 13 provinces and territories
- Healthcare center clustering
- Detailed facility information

### Quality Assurance Section
**Directory Standards:**

1. **Inclusion Criteria:**
   - Clinical expertise documentation
   - Specialty services verification
   - Geographic coverage requirements
   - Verified contact information

2. **Review Cycle:**
   - Quarterly comprehensive reviews
   - Real-time updates
   - Professional verification
   - Community feedback integration

### Backend Vetting Process
**Six-Step Process:**
1. Medical license verification
2. Hospital/clinic accreditation check
3. Specialty certification confirmation
4. Annual contact verification
5. Service offering updates
6. Quality assurance reviews

---

## 5. CONTACT PAGE (/contact)

### Contact Sections
**Four Specialized Contact Areas:**

1. **General Inquiries**
   - Email: info@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO
   - Response: 24-48 hours
   - Purpose: Media requests, collaboration opportunities

2. **Resource & Directory Updates**
   - Email: resources@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO ext. 2
   - Response: 3-5 business days
   - Purpose: Content submission, directory updates

3. **Membership & Support**
   - Email: support@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO ext. 3
   - Response: 1-2 business days
   - Purpose: Membership questions, support groups

4. **Healthcare Professionals**
   - Email: professionals@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO ext. 4
   - Response: 2-3 business days
   - Purpose: Professional resources, collaboration

### FAQ Section
**Six Detailed Categories:**
1. Resource access and availability
2. Membership benefits and requirements
3. Support group participation
4. Professional collaboration opportunities
5. Content submission guidelines
6. Technical support and accessibility

---

## 6. RESOURCES PAGE (/resources)

### Resource Categories
**Professional Tools:**
- Clinical assessment instruments
- Diagnostic decision aids
- Treatment protocols
- Patient education materials

### Upload Process
**Quality Control:**
- Peer review requirements
- Evidence-based standards
- Professional verification
- Regular content updates

### Search and Filtering
**Advanced Features:**
- Resource type classification
- Specialty area filtering
- Evidence level sorting
- Accessibility compliance

---

## 7. GET INVOLVED PAGE (/get-involved)

### Membership Benefits
**Professional Development:**
- Continuing education credits
- Network access
- Resource sharing
- Collaborative opportunities

### Volunteer Opportunities
**Engagement Areas:**
- Content review and validation
- Professional mentorship
- Event planning and execution
- Community outreach

### Events Section
**Three Categories:**
1. **Upcoming Events**: Future conferences and webinars
2. **Recent Events**: Past activity summaries
3. **Past Events**: Historical conference data

---

## 8. HEALTHCARE CENTER DATA

### Coverage Statistics
- **Total Centers**: 25+ facilities
- **Provincial Coverage**: All 13 provinces/territories
- **Center Types**: Hospitals, Specialty Centers, Research Facilities, Clinics

### Facility Information
**Standardized Data Points:**
- Center name and location
- Contact information (phone, email, website, address)
- Specialties and services offered
- Center type and certifications
- Establishment year
- Detailed descriptions

### Geographic Distribution
**Major Centers by Province:**
- **Ontario**: 4 centers (Toronto General, Princess Margaret, Ottawa Heart, Hamilton General)
- **Quebec**: 3 centers (Montreal Heart Institute, CHUM, Quebec Heart Institute)  
- **British Columbia**: 2 centers (Vancouver General, St. Paul's Hospital)
- **Additional provinces**: 1-2 centers each

---

## 9. AMYLOIDOSIS TYPE DETAIL PAGES

### AL Amyloidosis (/amyloidosis-types/al)
**Focus Areas:**
- Cardiac involvement patterns
- Treatment protocols
- Prognosis factors
- Clinical statistics

### ATTR Amyloidosis (/amyloidosis-types/attr)
**Content Sections:**
- Genetic vs. wild-type variants
- Neurologic manifestations
- Cardiac complications
- Therapeutic approaches

### Other Amyloidosis Types (/amyloidosis-types/other)
**Comprehensive Coverage:**
- AA Amyloidosis characteristics
- Localized amyloidosis forms
- Dialysis-related complications
- Rare variant presentations

---

## 10. FOOTER CONTENT

### Four-Column Layout
1. **Quick Links**: Major page navigation
2. **Contact Information**: All contact methods
3. **Legal & Privacy**: Policy documents
4. **Language Status**: Bilingual support indicators

### Social Media Links
- Professional networking platforms
- Educational resource channels
- Community engagement tools

---

## 11. ACCESSIBILITY FEATURES

### WCAG 2.1 Level AA Compliance
**Accessibility Tools:**
- Font size adjustment (12px-24px)
- High contrast modes
- Cursor size options
- Reduced motion support
- Dyslexia-friendly fonts
- Screen reader optimization

### Keyboard Navigation
- Skip links implementation
- Focus indicators
- Semantic HTML structure
- ARIA labels and announcements

---

## 12. MULTILINGUAL SUPPORT

### Language Implementation
- **Primary**: English (fully implemented)
- **Secondary**: French (comprehensive translation system)
- **Status Indicators**: "Available" / "Coming Soon" tags
- **Persistent Settings**: localStorage-based language preference

### Translation Coverage
- All major content sections
- User interface elements
- Form labels and validation messages
- Navigation and menu items
- Error messages and notifications

---

---

## 13. TECHNICAL IMPLEMENTATION NOTES

### Content Management System
- **Translation Keys**: Over 200+ translation keys for comprehensive bilingual support
- **Dynamic Content**: Real-time healthcare center data integration
- **Content Sources**: Professional medical resources and verified clinical information

### Brand Consistency Guidelines
- **Color Usage**: Consistent #00AFE6 and #00DD89 gradients across all sections
- **Typography Hierarchy**: Rosarivo for headings, Mulish for body text
- **Component Styling**: Unified rounded-3xl corners and shadow-2xl depth effects
- **Animation Standards**: Framer Motion with consistent duration and easing

### Content Update Workflow
1. **Source Verification**: All medical content requires professional validation
2. **Translation Process**: English-first development with comprehensive French translation
3. **Quality Assurance**: Multi-stage review process for accuracy and consistency
4. **Accessibility Compliance**: WCAG 2.1 Level AA standards throughout all content

### Performance Optimization
- **Image Compression**: Automated optimization with 70-75% quality settings
- **Lazy Loading**: React.lazy() implementation for all pages
- **Content Delivery**: Optimized bundle sizes and efficient caching strategies
- **Real-time Updates**: Dynamic healthcare center data with 5-minute cache refresh

---

## 14. CONTENT MAINTENANCE SCHEDULE

### Daily Updates
- Healthcare center contact verification
- Event calendar synchronization
- Resource submission processing

### Weekly Reviews
- Content accuracy verification
- Translation consistency checks
- User feedback integration

### Monthly Assessments
- SEO content optimization
- Accessibility compliance audits
- Performance metrics analysis
- Brand consistency reviews

### Quarterly Overhauls
- Comprehensive content audits
- Healthcare center database verification
- Clinical guideline updates
- Technology stack assessments

---

This documentation serves as the complete content reference for the Canadian Amyloidosis Society website, ensuring consistency across all pages and maintaining the professional, evidence-based approach that characterizes the platform. The content management system supports both English and French languages with comprehensive healthcare provider data covering all Canadian provinces and territories.